Blood transfusion is a clinical critical patients and the prevention and treatment of chronic diseases, can save countless peoples life safety, but because everyones blood composition is different, has a high complexi...Blood transfusion is a clinical critical patients and the prevention and treatment of chronic diseases, can save countless peoples life safety, but because everyones blood composition is different, has a high complexity, and the patients physical quality is also quite different, adverse reactions may occur in blood transfusion. If adverse reactions occur during blood transfusion, it will seriously affect the life safety of the patient, in order to reduce or prevent the occurrence of delayed hemolytic blood transfusion phenomenon. The study mainly analyzes the safety problems during the blood transfusion process, and explores the value of irregular antibody screening before blood transfusion in preventing clinical blood transfusion safety. Retroanalysis of 100 blood transfusion patients in a grade A hospital from March 2019 to December 2020, and summarize the impact of irregular antibody screening before transfusion on transfusion adverse reactions. As a result, in the retrospective study of antibody screening, it was obviously found that the adverse reactions of irregular antibody screening were 0.458 times that of no irregular antibody screening, so it can be seen that the probability of adverse reactions in blood transfusion could be greatly reduced after receiving irregular antibody screening.展开更多
文摘Blood transfusion is a clinical critical patients and the prevention and treatment of chronic diseases, can save countless peoples life safety, but because everyones blood composition is different, has a high complexity, and the patients physical quality is also quite different, adverse reactions may occur in blood transfusion. If adverse reactions occur during blood transfusion, it will seriously affect the life safety of the patient, in order to reduce or prevent the occurrence of delayed hemolytic blood transfusion phenomenon. The study mainly analyzes the safety problems during the blood transfusion process, and explores the value of irregular antibody screening before blood transfusion in preventing clinical blood transfusion safety. Retroanalysis of 100 blood transfusion patients in a grade A hospital from March 2019 to December 2020, and summarize the impact of irregular antibody screening before transfusion on transfusion adverse reactions. As a result, in the retrospective study of antibody screening, it was obviously found that the adverse reactions of irregular antibody screening were 0.458 times that of no irregular antibody screening, so it can be seen that the probability of adverse reactions in blood transfusion could be greatly reduced after receiving irregular antibody screening.
